Prevalence, severity and predictors of hand eczema in patients treated for atopic dermatitis: a cross-sectional observational study
- PMID: 40156732
- DOI: 10.1007/s00403-025-04138-6
Prevalence, severity and predictors of hand eczema in patients treated for atopic dermatitis: a cross-sectional observational study
Abstract
Background: Hand eczema (HE) is common among individuals with atopic dermatitis (AD), yet data on its prevalence and predictors in this population remain limited.
Methods: A prospective, dermatology practice-based study was performed in adult patients with AD to determine the prevalence of HE and associations with HE severity. AD severity was assessed using Investigator's Global Assessment (IGA), body surface area (BSA), Eczema Area and Severity Index (EASI), Scoring AD (SCORAD), objective component of SCORAD (O-SCORAD), Patient-reported Global AD severity (PtGA) and Patient-Oriented Eczema Measure (POEM).
Results: Active HE was observed in 135 (45.9%) patients, including 83 (61.5%) with mild, 43 (31.9%) with moderate and 9 (6.7%) with severe HE. Lesions affected the dorsal hands or digits in 231 (78.6%), wrists in 69 (51.1%), palmar hands or digits in 113 (38.4%), with nail dystrophy present in only 7 (5.2%). There were no significant associations of HE severity with demographics or self-reported history of atopic disease. However, in bivariable and multivariable logistic regression models, HE severity was associated with moderate and severe IGA, BSA, EASI, SCORAD, O-SCORAD, PtGA and POEM.
Conclusions: HE was highly prevalent in adult patients with AD treated in the dermatology setting, particularly among patients with moderate-severe AD.
Keywords: Atopic dermatitis; Eczema; Hand eczema; Severity.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: JIS has received honoraria as a consultant and/or advisory board member for Abbvie, Alamar, Aldena, Amgen, AObiome, Apollo, Arcutis, Arena, Asana, Aslan, Attovia, BioMX, Biosion, Bodewell, Boehringer-Ingelheim, Bristell-Meyers Squibb, Cara, Castle Biosciences, Celgene, Connect Biopharma, Corevitas, Dermavant, Eli Lilly, FIDE, Galderma, GlaxoSmithKline, Incyte, Inmagene, Invea, Kiniksa, Leo Pharma, Merck, My-Or Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT, Recludix, Regeneron, Sandoz, Sanofi-Genzyme, Shaperon, TARGET-RWE, Teva, Union, UpToDate JPT was previously an advisor for AbbVie, Almirall, Arena Pharmaceuticals, Coloplast, OM Pharma, Aslan Pharmaceuticals, Union Therapeutics, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, a speaker for AbbVie, Almirall, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, and received research grants from Pfizer, Regeneron, and Sanofi-Genzyme. He is currently an employee of LEO Pharma.
References
-
- Heede NG, Thyssen JP, Thuesen BH, Linneberg A, Johansen JD (2015) Anatomical patterns of dermatitis in adult filaggrin mutation carriers. J Am Acad Dermatol 72(3):440–448 - PubMed
-
- Weidinger S, Novak N (2024) Hand eczema. Lancet (Br Ed) 404(10470):2476–2486. https://doi.org/10.1016/S0140-6736(24)01810-5
-
- Kaae J, Menne T, Carlsen BC, Zachariae C, Thyssen JP (2012) The hands in health and disease of individuals with filaggrin loss-of-function mutations: clinical reflections on the hand eczema phenotype. Contact Dermatitis 67(3):119–124 - PubMed
-
- Simpson EL, Thompson MM, Hanifin JM (2006) Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis 17(3):123–127 - PubMed
-
- Bauer A, Brans R, Brehler R, Büttner M, Dickel H, Elsner P, Fartasch M, Herzog C, John S, Köllner A, Maul J, Merk H, Molin S, Nast A, Nikolakis GD, Schliemann S, Skudlik C, Weisshaar E, Werfel T, Zidane M, Worm M (2023) S2k guideline diagnosis, prevention, and therapy of hand eczema. J Dtsch Dermatol Ges 21(9):1054–1074. https://doi.org/10.1111/ddg.15179 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous